The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Publications

Found 8105 results
2019
Thompson A, Carroll K, A I, et al. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. Clinical journal of the American Society of Nephrology : CJASN. 2019;14:469 - 481. doi:10.2215/CJN.08600718.
Garg A, Chan M, Cuerden M, et al. Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial', CMAJ : Canadian Medical Association journal = journal de l. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2019;191:E247 - E256. doi:10.1503/cmaj.181644.
Singh G, Sharma S, Bansal R, et al. A home-based, primary-care model for epilepsy care in India: Basis and design. Epilepsia Open. 2019. doi:10.1002/epi4.12311.
Redfern J, Hyun K, Singleton A, et al. ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial. BMJ Open. 2019;9. doi:10.1136/bmjopen-2018-023863.
Kapoor D, Gupta Y, Desai A, et al. Lifestyle intervention programme for Indian women with history of gestational diabetes mellitus. Global Health, Epidemiology and Genomics. 2019;4. doi:10.1017/gheg.2018.18.
Bath P, Scutt P, Anderson C, et al. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. The Lancet. 2019;393:1009 - 1020. doi:10.1016/S0140-6736(19)30194-1.
Nasi L, Martins S, Rebello L, et al. Response to Letter to the Editor: New Insights and Old Questions in Acute Stroke Blood Pressure Control. Neurocritical Care. 2019. doi:10.1007/s12028-019-00683-x.
Ju A, Chow B, Ralph A, et al. Patient-reported outcome measures for life participation in kidney transplantation: A systematic review. American Journal of Transplantation. 2019. doi:10.1111/ajt.15267.
Xu Y, Neuen D, Glozier N, et al. Disability patterns over the first year after a diagnosis of epilepsy. Clinical Neurology and Neurosurgery. 2019;179:60 - 65. doi:10.1016/j.clineuro.2019.02.022.
Jan S. Making sense of paying for performance in health care: Short-term targets versus patient-relevant outcomes. Australian Health Review. 2019. doi:10.1071/AH18178.
Robards F, Kang M, Steinbeck K, et al. Health care equity and access for marginalised young people: A longitudinal qualitative study exploring health system navigation in Australia 11 Medical and Health Sciences 1117 Public Health and Heal. International Journal for Equity in Health. 2019;18. doi:10.1186/s12939-019-0941-2.
Angell B, Prinja S, Gupt A, Jha V, Jan S. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana and the path to universal health coverage in India: Overcoming the challenges of stewardship and governance. PLoS medicine. 2019;16:e1002759. doi:10.1371/journal.pmed.1002759.
Jun M, Jardine M, Perkovic V, et al. Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study. PLoS ONE. 2019;14. doi:10.1371/journal.pone.0213192.
Cullen P, Hunter K, Clapham K, et al. Road user behaviour, attitudes and crashes: A survey of Aboriginal and Torres Strait Islander people in Australia. Injury Prevention. 2019. doi:10.1136/injuryprev-2018-043011.
Toyama T, Neuen B, Jun M, et al. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis. Diabetes, Obesity and Metabolism. 2019. doi:10.1111/dom.13648.
Jan S. Making sense of paying for performance in health care: short-term targets versus patient-relevant outcomes. Aust Health Rev. 2019. doi:10.1071/AH18178.
Angell B, Prinja S, Gupt A, Jha V, Jan S. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana and the path to universal health coverage in India: Overcoming the challenges of stewardship and governance. PLoS Med. 2019;16:e1002759. doi:10.1371/journal.pmed.1002759.
Campbell C, Li L, Kotwal S, et al. Under-detection of Acute Kidney Injury in Hospitalised Patients - A Retrospective, multi-site, longitudinal study. Intern Med J. 2019. doi:10.1111/imj.14264.
Lipman J, Brett S, De W, et al. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Crit Care Resusc. 2019;21:63 - 68. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30857514.
Jun M, Jardine M, Perkovic V, et al. Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study. PLoS One. 2019;14:e0213192. doi:10.1371/journal.pone.0213192.
Ha J, Badve S, Jun M. Recent evidence for direct oral anticoagulants in chronic kidney disease. Curr Opin Nephrol Hypertens. 2019. doi:10.1097/MNH.0000000000000493.
Jan S. Making sense of paying for performance in health care: short-term targets versus patient-relevant outcomes. Australian health review : a publication of the Australian Hospital Association. 2019. doi:10.1071/ah18178.
Angell B, Prinja S, Gupt A, Jha V, Jan S. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana and the path to universal health coverage in India: Overcoming the challenges of stewardship and governance. PLoS medicine. 2019;16:e1002759. doi:10.1371/journal.pmed.1002759.
Hanley D, Thompson R, Rosenblum M, et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. The Lancet. 2019;393:1021 - 1032. doi:10.1016/S0140-6736(19)30195-3.
Gray N, Zuo L, Hong D, et al. Quality of life in caregivers compared with dialysis recipients: the Co-ACTIVE sub-study of the ACTIVE Dialysis trial. Nephrology (Carlton). 2019. doi:10.1111/nep.13530.

Pages